"I'm a speculative buyer. They've got a lot going on," said Jim Cramer.
Let's check out the charts and indicators of this pharmaceutical company focused on developing therapeutics to improve cardiovascular health.
In this daily bar chart of AMRN, below, we can see that prices have largely traded sideways the past 12 months. AMRN has crossed above and below the 50-day and 200-day moving average lines a number of times. Matching the price action the On-Balance-Volume (OBV) line has moved sideways and the Moving Average Convergence Divergence (MACD) oscillator has crossed above and below the zero-line several times in the past year.